Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma

Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma

Background: Esophageal cancer is one of the most common gastrointestinal malignancies worldwide, with high morbidity and mortality in China. The clinical importance of the interaction between hypoxia and immune status in the tumor microenvironment has been established in esophageal squamous cell car...

Full description

Bibliographic Details
Main Authors: Han, S.-G (Author), Lian, L. (Author), Shen, X.-M (Author), Teng, S.-B (Author), Wang, W.-J (Author), Xia, Y.-Y (Author), Xu, X.-F (Author), Zheng, Y. (Author), Zhou, C. (Author)
Format: Article
Language:English
Published: AME Publishing Company 2022
Subjects:
adult
aged
apelin
Article
cancer patient
cancer prognosis
cancer survival
classifier
clinical study
controlled study
differential gene expression
epidermal growth factor receptor
Esophageal cancer
esophageal squamous cell carcinoma
fatty acid binding protein 7
female
high risk population
human
human tissue
hypoxia
immune
immune-related gene
interleukin 17 receptor
interleukin 17 receptor D
low risk population
major clinical study
male
microenvironment
myosin heavy chain
myosin heavy chain 9
nomogram
oncostatin M
overall survival
prognosis
prognostic assessment
risk model
RNA sequencing
survival prediction
synaptotagmin like 1 protein
toll like receptor 1
tumor hypoxia
tumor microenvironment
unclassified drug
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items